WASHINGTON - A gene known for its link with longevity in roundworms and humans could affect the function of stem cells that generate new neurons in the adult brain, according to researchers at Stanford University School of Medicine.
The rodent study indicated that the gene might play an important role in maintaining cognitive function during aging.
“It’s intriguing to think that genes that regulate life span in invertebrates may have evolved to control stem cell pools in mammals,” said Dr. Anne Brunet, senior author of the research.
Adult brain maintains two small caches of neural stem cells, which can both self-renew and give rise to neurons and other cells known as oligodendrocytes and astrocytes.
Properly balancing these functions allows you to generate new nerve cells as needed while also maintaining a robust neural stem cell pool.
The researchers studied a family of transcription factors called FoxO known to be involved in proliferation, differentiation and programmed cell death.
FoxO genes are required for the extreme longevity seen in some strains of laboratory roundworms, and a single mutation in the FoxO3 gene has recently been associated with long life in Japanese, German, American and Italian populations.
“We wanted to know if FoxO3 could be involved in regulating the pool of neural stem cells,” said Brunet.
For this, they examined laboratory mice in which the FoxO3 gene was knocked out.
They used mice of three different ages, both with and without the gene: 1-day-old (newborns), 3-month-old (young adult) and 1-year-old (middle age).
They found that, overall, adult and middle-aged mice without FoxO3 had fewer neural stem cells than did age-matched mice with this regulatory protein.
There were no significant differences between the newborn mice with and without FoxO3, suggesting that FoxO3 loss only affects adults.
The researchers also discovered that the few stem cells found in the adult mice without FoxO3 more rapidly churned out neural cell precursors - those cells destined to become new neurons - than did the mice with normal FoxO3 levels.
In fact, the brains of the mice that lacked FoxO3 were heavier than the control group, perhaps because they were burning through their pool of neural stem cells by making too many new nerve cells.
After looking at the neural stem cell in a laboratory dish, they found that those from young and middle-aged adult mice lacking FoxO3 - but not those from newborn mice - seemed to be compromised in their ability to self-renew and to generate the three types of nerve cells.
They also discovered that the FoxO3 protein regulates the expression of genes involved in quiescence and differentiation in cells.
The researchers concluded that FoxO3 may be needed for the stem cells to re-enter a waiting state called quiescence that normally occurs after dividing.
Cells that are unable to enter quiescence are less able to self-renew and may lose their ability to become any of the three nerve cell types.
Together, the research results suggest that FoxO3 is important to regulate the pool of neural stem cells in the adult brain.
The study will be published Nov. 6 in Cell Stem Cell. (ANI)
Related News
Targeted immunotherapy may help treat lymphomaOctober 31st, 2009 WASHINGTON - A new study has revealed that targeted immunotherapy has been found effective in treating lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT). Lymphoma is a cancer of white blood cells called lymphocytes that are largely responsible for maintaining the body's immunity, and EBV is one of the most common human viruses that can have a long-lasting impact on the body's immune system.
Artificial sperm and eggs 'just 5 years away'October 29th, 2009 LONDON - In a revolutionary discovery, researchers have successfully transformed human embryonic stem cells into germ cells, the embryonic cells that ultimately give rise to sperm and eggs. The breakthrough will allow researchers to observe human germ cells-previously inaccessible-in laboratory dishes.
University of Michigan awarded 13 fed stimulus grants totaling $6.8M for stem cell researchOctober 22nd, 2009 U. Mich. awarded $6.8M in grants for stem cellsDETROIT — The University of Michigan has received 13 federal stimulus grants worth $6.8 million for stem cell research — a sign of the state's growing clout since voters last year eased restrictions in the emerging field that seeks treatments and cures for numerous diseases. The Ann Arbor university released the findings Thursday after analyzing about $5 billion in grants awarded this year by the National Institutes of Health as part of the $787 billion economic stimulus program.
Stem cell-based therapy offers new hope for kidney disease patientsOctober 16th, 2009 WASHINGTON - Researchers have suggested that several stem cell based therapies can help treat patients with Alport syndrome. Most often occurring in boys, Alport syndrome causes progressive kidney disease leading to kidney failure at a young age.
Mosses may provide new "compass" for stem cell researchSeptember 30th, 2009 WASHINGTON - Mosses can now act as a novel "compass" for scientists to better program stem cells for medical purposes, according to Israeli and German scientists. Dr. Nir Ohad of Tel Aviv University's Department of Plant Sciences and Prof.
Stem cell injections offer new hope for kids with motor neuron diseaseSeptember 23rd, 2009 LONDON - Scientists have obtained some promising results by treating mice bred to develop a form of motor neuron disease that affects children, with with injections of stem cells into the spinal cord. Giacomo Comi, of the University of Milan in Italy, has revealed that the treatment extended the lives of the mice beyond and kept them more mobile, giving hope that similar approaches might work in humans as well.
Scientists find how stem cells make skinSeptember 14th, 2009 LONDON - Scientists at the European Molecular Biology Laboratory (EMBL) have identified two proteins that prompt stem cells to develop into skin cells. They hope that the new findings could help understand basic mechanisms involved not only in formation of skin, but also on skin cancer and other epithelial cancers.
Scientists isolate master gene that turns cells into bug killersSeptember 14th, 2009 LONDON - Scientists have isolated a master gene that causes blood stem cells to turn into disease-fighting 'natural killer' (NK) cells. The discovery could potentially help boost the body's production of these frontline tumour killing cells, creating new ways to treat cancer.
Master gene that switches on disease-fighting cells identifiedSeptember 14th, 2009 LONDON - British scientists have identified the master gene, called E4bp4, that causes blood stem cells to turn into disease-fighting 'Natural Killer' (NK) immune cells. The discovery, by researchers at Imperial College London, UCL and the Medical Research Council's National Institute for Medical Research, could one day help scientists boost the body's production of these frontline tumour-killing cells, creating new ways to treat cancer.
Turning off oncogene may inhibit lung cancer stem cells' growthSeptember 9th, 2009 WASHINGTON - A lung cancer oncogene, called PKCiota, is necessary for the proliferation of lung cancer stem cells, and turning it off could act as a key for the treatment of this deadly disease, according to scientists at the Mayo Clinic campus in Florida. These stem cells are rare and powerful master cells that manufacture the other cells that make up lung tumours, and are resistant to chemotherapy treatment.
Liposuction leftovers can boost stem cell productionSeptember 8th, 2009 WASHINGTON - Blobs of fat removed during liposuction conceal cells that can be more quickly and easily converted into stem cells than skin cells most often used by researchers. "We've identified a great natural resource," said Stanford University Medical Centre (SUMC) surgery professor Michael Longaker who described liposuction leftovers as 'liquid gold' and co-authored the study.
Novel method to make safer human stem cells uses just one geneAugust 29th, 2009 LONDON - Inching closer to curing diseases like Parkinson's using cells generated from a patient's own body, researchers have successfully reprogrammed human nerve cells back to an embryo-like state by using just a single gene. It is known that embryonic stem cells are pluripotent - they can develop into any of the body's cell types.
